WUSTL, UC Boulder to Conduct Metagenomics Studies of Inflammatory Bowel Disease | GenomeWeb
NEW YORK (GenomeWeb News) – Genomics researchers at Washington University in St. Louis and at the University of Colorado at Boulder will work as partners with the Crohn’s and Colitis Foundation of America to study how microbes in the human gut contribute to inflammatory bowel disease, the foundation said today. 
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.